Target intelligence / Profile preview

Drug carrier

Molecular classification
Lipid-based carriers (liposomes, solid lipid nanoparticles), Polymer-based carriers (polymeric micelles, microspheres, nanoparticles), Protein-based carriers (albumin, keratin, zein, gliadin), Carbon-based carriers (nanodiamonds, carbon nanomaterials), Dendrimers, Cell-based carriers (erythrocytes), Virosomes
01

Overview

Drug carriers are biocompatible vehicles designed to transport pharmaceutical compounds within the body to achieve therapeutic effects. They serve as a crucial component in modern drug delivery systems, enhancing drug efficacy while minimizing side effects[5]. These carriers can improve pharmacokinetics, provide controlled release, increase drug solubility, enable targeted delivery to specific tissues or cells, and protect drugs from degradation[3][4]. The design and selection of drug carriers depend on the specific therapeutic application, drug properties, and desired delivery route. Carriers can be engineered to respond to various stimuli such as pH changes, enzymatic activity, or redox conditions, allowing for precise control over drug release at the target site[7][10]. Recent advances in formulation technologies have enabled control over not just material selection and surface chemistry but also the overall geometry and plasticity of drug carriers, which can significantly impact their ability to overcome biological barriers[7].

Other names
Drug delivery systemDrug delivery vehicleDrug delivery carrier
02

Mechanism of action

Encapsulation of drugs within carrier structures; Surface coupling of drugs to carriers; Controlled release through diffusion; Triggered release by environmental stimuli (pH, enzymes, glutathione); Enhanced permeability and retention (EPR) effect for tumor targeting; Ligand-directed targeting to specific tissues; Protection from enzymatic degradation

03

Biological functions

Drug transportControlled drug releaseProtection of drugs from degradationEnhanced drug solubilityTargeted drug deliveryImproved bioavailabilityReduced toxicity
04

Disease associations

Cancer treatmentInfectious disease managementNeurological disordersHIV treatmentInflammatory conditions
05

Safety considerations

Potential immunogenicityStability issues during storagePremature drug leakageChallenges in quality controlLimited control over drug release kineticsDifficulties in scale-up manufacturing
06

Interacting drugs

Doxorubicin

4 more in the full profile.

Beyond the preview

Go deeper on Drug carrier.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Drug carrier.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call